Boehringer Ingelheim Vetmedica, Inc. has given the Pyramid® 5 package a new look.
(ST. JOSEPH, MO—December 17, 2010) -- Boehringer Ingelheim Vetmedica, Inc. has unveiled a new packaging design for Pyramid® 5. The Pyramid brand of vaccines was acquired by Boehringer Ingelheim Vetmedica, Inc. in late 2009 and the product has been sold in the Fort Dodge packaging until now. Pyramid 5 is the first product from the Pyramid family to be presented in the new package.
The new box is still the familiar yellow, but the design now aligns Pyramid 5 more closely with the rest of the Boehringer Ingelheim Vetmedica family of products.
Although the packaging for Pyramid 5 has changed, you’ll still find the same powerful protection to aid in the prevention of disease caused by BRSV, BVD Types 1 and 2, PI3 and IBR. In addition, this product aids in the prevention of persistent BVD Types 1 and 2 infections of fetal calves.
For more information on Pyramid 5, contact your veterinarian or Boehringer Ingelheim Vetmedica, Inc. representative.
Boehringer Ingelheim Vetmedica, Inc. (St. Joseph, Mo.) is a subsidiary of Boehringer Ingelheim Corporation based in Ridgefield, Conn., and a member of the Boehringer Ingelheim group of companies.
The Boehringer Ingelheim group is one of the world’s 20 leading pharmaceutical companies. Headquartered in Ingelheim, Germany, it operates globally with 142 affiliates in 50 countries and approximately 41,500 employees. Since it was founded in 1885, the family-owned company has been committed to researching, developing, manufacturing and marketing novel products of high therapeutic value for human and veterinary medicine.
In 2009, Boehringer Ingelheim posted net sales of U.S. $17.7 billion (12.7 billion euro) while spending 21 percent of net sales in its largest business segment, Prescription Medicines, on research and development.
For more information, please visit: www.bi-vetmedica.com.